Knockout of secretin receptor reduces large cholangiocyte hyperplasia in mice with extrahepatic cholestasis induced by bile duct ligation.
about
Stem/Progenitor Cell Niches Involved in Hepatic and Biliary RegenerationPhysiology of cholangiocytesCombination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice.Regulators of Cholangiocyte Proliferation.Recent advances on the mechanisms regulating cholangiocyte proliferation and the significance of the neuroendocrine regulation of cholangiocyte pathophysiology.Regulation of biliary proliferation by neuroendocrine factors: implications for the pathogenesis of cholestatic liver diseases.Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease.Knockout of the neurokinin-1 receptor reduces cholangiocyte proliferation in bile duct-ligated miceActivation of the renin-angiotensin system stimulates biliary hyperplasia during cholestasis induced by extrahepatic bile duct ligation.Secretin is not necessary for exocrine pancreatic development and growth in mice.Castration inhibits biliary proliferation induced by bile duct obstruction: novel role for the autocrine trophic effect of testosterone.Differential determinants for coupling of distinct G proteins with the class B secretin receptor.Functional and structural features of cholangiocytes in health and disease.Development and functional characterization of extrahepatic cholangiocyte lines from normal rats.Insignificant effect of secretin in rodent models of polycystic kidney and liver disease.Effects of warm ischemia time on biliary injury in rat liver transplantationActivation of alpha(1) -adrenergic receptors stimulate the growth of small mouse cholangiocytes via calcium-dependent activation of nuclear factor of activated T cells 2 and specificity protein 1.Modulation of the biliary expression of arylalkylamine N-acetyltransferase alters the autocrine proliferative responses of cholangiocytes in rats.Autocrine regulation of biliary pathology by activated cholangiocytes.Expression of vascular endothelial growth factors and their receptors by hepatic progenitor cells in human liver diseases.Nonselective inhibition of prostaglandin-endoperoxide synthases by naproxen ameliorates acute or chronic liver injury in animals.Recent advances in the morphological and functional heterogeneity of the biliary epitheliumThe physiological roles of secretin and its receptor.Inhibition of the liver expression of arylalkylamine N-acetyltransferase increases the expression of angiogenic factors in cholangiocytes.The Neuropeptide Galanin Is Up-Regulated during Cholestasis and Contributes to Cholangiocyte Proliferation.Melatonin inhibits cholangiocyte hyperplasia in cholestatic rats by interaction with MT1 but not MT2 melatonin receptors.The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice.Secretin, at the hub of water-salt homeostasis.Mechanisms of cholangiocyte responses to injury.Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice.The role of the secretin/secretin receptor axis in inflammatory cholangiocyte communication via extracellular vesicles.Prolonged administration of secretin to normal rats increases biliary proliferation and secretin-induced ductal secretory activity.Lipolytic actions of secretin in mouse adipocytes.Role of cysteinyl-leukotrienes for portal pressure regulation and liver damage in cholestatic rat livers.Exposure of mice to 1, 2-dichloropropane induces CYP450-dependent proliferation and apoptosis of cholangiocytes.Melatonin inhibits hypothalamic gonadotropin-releasing hormone release and reduces biliary hyperplasia and fibrosis in cholestatic rats.Knockdown of Hepatic Gonadotropin-Releasing Hormone by Vivo-Morpholino Decreases Liver Fibrosis in Multidrug Resistance Gene 2 Knockout Mice by Down-Regulation of miR-200b.Knockout of histidine decarboxylase decreases bile duct ligation-induced biliary hyperplasia via downregulation of the histidine decarboxylase/VEGF axis through PKA-ERK1/2 signaling.The Secretin/Secretin Receptor Axis Modulates Ductular Reaction and Liver Fibrosis through Changes in Transforming Growth Factor-β1-Mediated Biliary Senescence
P2860
Q26765898-215669A2-DECB-41FC-83CF-A22C863B0ADFQ27008523-CD1A3606-3C28-485F-9E14-24476FF4F9C6Q33840550-9DF70FB5-F703-49F9-A4DB-004A7E233808Q33863341-2F808B60-C1F9-484E-8000-73D3E1D7FC9FQ34358007-E5B2089B-F99B-4732-8F46-332B42E1ABECQ34755613-00B24D1E-8737-46B3-9C40-49C0AFE6EA8AQ35088371-90D63E9B-80DB-4FEE-9EA9-91CB2CBF7AAAQ35159620-DF24E279-7BFF-41A4-89B1-67F5E6C8817DQ35437089-124A977D-542D-432E-A9D3-FE9D7A96D1ABQ35562119-62D53FCE-833E-45F5-87CC-C34351FDBFF2Q35601290-3BF79F03-8E23-4EED-AAB4-99448D6D16D3Q35900688-0BC93803-4E49-4965-8C41-BBF7F1FC2D90Q35933236-DEF02FB0-9555-4FB8-8029-612947A671E6Q36219756-0004BD99-F4BF-45B0-BC0C-55074E671608Q36312676-71A92737-AF5C-41D1-B231-3B6FA0A6D53CQ36410423-823E83A9-F420-4676-A77C-9089A770A601Q36466409-A8406BCA-67CC-408A-9FB1-95EF5BE8154AQ36592748-2CEE7D07-D2FB-4280-943B-56E358EAD672Q37175512-53EC7C78-ADD1-4739-A79F-858F5E139A77Q37584658-B9AE2719-0FE9-4E70-AE1B-2ED454E2162BQ37621796-7F962D2D-112F-4EC9-8398-7E5A897A26EBQ37662251-D0C58A59-D11B-423A-8B99-2348306D6803Q38261684-F8DF5D4A-4B51-4CE7-B89D-73C4DBEFC599Q38280635-911F0A97-0DDE-4AE8-9663-56C399D7CF70Q38289054-60717BF7-382B-4B46-8C76-42C18A8346FAQ38682140-2459FE80-3138-42AD-9F48-E8A3D30373A3Q38775284-CDF727AB-C40E-462B-A1AF-64E88A71E914Q38859778-40D5EE6B-98BE-4423-8DEE-388AF7D55F9FQ39397552-F215F2EE-842D-4ADA-BC1A-1F48D99957BCQ39979273-81D614A0-5FF8-420F-8D99-F66A63E6BF61Q40052358-4A6BB052-4CF2-48CC-80E0-8A4809CAA0B4Q41351001-1EECF7DA-38C2-44EC-A804-58DAC607D49BQ41862301-AE740058-34D0-4FDE-BA3A-54F4883AEB85Q42445325-EB411AEE-9BA3-4D3D-B9A4-324CD0248A96Q47684040-8E6EB3AE-8359-4F4D-9086-600E3F6B3B3FQ47813887-3691B57A-1773-47E6-B5A8-DD98DB5E8A6BQ47886786-391CD925-3D1C-442B-86A8-1F49194F23E0Q48223400-075589F2-C88D-46BF-B787-89CC10A87543Q57106646-B82FAD16-3078-4B00-A0C9-6DFB09E62771
P2860
Knockout of secretin receptor reduces large cholangiocyte hyperplasia in mice with extrahepatic cholestasis induced by bile duct ligation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Knockout of secretin receptor ...... induced by bile duct ligation.
@ast
Knockout of secretin receptor ...... induced by bile duct ligation.
@en
Knockout of secretin receptor ...... induced by bile duct ligation.
@nl
type
label
Knockout of secretin receptor ...... induced by bile duct ligation.
@ast
Knockout of secretin receptor ...... induced by bile duct ligation.
@en
Knockout of secretin receptor ...... induced by bile duct ligation.
@nl
prefLabel
Knockout of secretin receptor ...... induced by bile duct ligation.
@ast
Knockout of secretin receptor ...... induced by bile duct ligation.
@en
Knockout of secretin receptor ...... induced by bile duct ligation.
@nl
P2093
P2860
P356
P1433
P1476
Knockout of secretin receptor ...... induced by bile duct ligation.
@en
P2093
Antonio Franchitto
Billy K Chow
Candace Wise
David Dostal
Eugenio Gaudio
Gianfranco Alpini
Guido Carpino
Heather Francis
Julie Venter
P2860
P304
P356
10.1002/HEP.23657
P407
P577
2010-07-01T00:00:00Z